MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Trajectories of prediagnostic functioning in Parkinson’s disease during 14 years before clinical onset

    S. Darweesh, V. Verlinden, B. Stricker, A. Hofman, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

    Objective: We studied trajectories of daily functioning and motor and nonmotor features during 14 years preceding clinical Parkinson's disease (PD) onset. Background: In the ten…
  • 2016 International Congress

    Cancer comorbidity among PD patients; a population based large-scale cohort study

    R. Gurel, N. Giladi, V. Rozani, T. Gurevich, B. El-Ad, B. Hemo, J. Tsamir, C. Peretz (Tel Aviv, Israel)

    Objective: To estimate the risk of incident cancer; any type and specific types‎ in PD (Parkinson's disease) patients, by sex; and to compare it to…
  • 2016 International Congress

    Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population

    G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge-de Sarachaga, D. Cruz-Fino, J. Pascacio-Astudillo, R. Llorens-Arenas (Mexico City, Mexico)

    Objective: To determine the role of cardiovascular risk factors such as diabetes, hypertension, obesity, dyslipidemia in the PD severity of motor and non motor symptoms,…
  • 2016 International Congress

    Consumption of Yerba Mate (Ilex Paraguariensis) in Parkinson’s disease patients from Uruguay

    I. Amorín, A. Lescano, N. Ramírez, V. Raggio, R. Buzó (Montevideo, Uruguay)

    Objective: To know the consumption habits of Yerba Mate in a population of Parkinson's disease (PD) patients from Uruguay. To compare the consumption habits of…
  • 2016 International Congress

    The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

    V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)

    Objective: To investigate whether the predominant initial PD motor symptom is associated with gender or age of onset of PD in Sri Lanka. Background: Studies…
  • 2016 International Congress

    Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort

    P. Mahlknecht, A. Gasperi, P. Willeit, S. Kiechl, H. Stockner, J. Willeit, G. Rungger, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To quantify the prevalence of prodromal phase of Parkinson's disease (PD) defined per 2015 MDS research criteria and their potential to predict incident clinically…
  • 2016 International Congress

    Physical therapy practice variability and outcomes for people with Parkinson’s disease: Data from the National Parkinson Foundation quality improvement initiative (NPF-QII)

    M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

    Objective: To (1) describe current variability in physical therapy (PT) use by people with Parkinson's disease (PD) and to (2) examine the association between PT…
  • 2016 International Congress

    Vagotomy and Parkinson’s disease risk: A Swedish register-based matched cohort study

    B. Liu, F. Fang, N.L. Pedersen, A. Tillander, J.F. Ludvigsson, A. Ekbom, P. Svenningsson, H. Chen, K. Wirdefeldt (Stockholm, Sweden)

    Objective: To examine whether a vagotomy decreases the risk of later Parkinson's disease (PD). Background: It has been hypothesized that the α-synuclein pathology of PD…
  • 2016 International Congress

    Comparing psychosocial risk factors in patients with functional movement disorders and patients with psychogenic non-epileptic seizures

    C.W. Maurer, G.M. Capitan, G. Limachia, K. LaFaver, E. Considine, A. Curran, W.C. LaFrance, M. Hallett (Bethesda, MD, USA)

    Objective: To compare the trauma histories and psychopathological comorbidities in patients with functional (psychogenic) movements disorders (FMD) to patients with psychogenic non-epileptic seizures (PNES). Background:…
  • 2016 International Congress

    Gender effect on non-motor symptoms in Parkinson’s disease: Are men more at risk for most of them?

    R. Vasta, A. Nicoletti, G. Mostile, G. Nicoletti, G. Arabia, G. Iliceto, P. Lamberti, R. Marconi, L. Morgante, P. Barone, A. Quattrone, M. Zappia (Catania, Italy)

    Objective: To evaluate the burden of non-motor symptoms (NMS) among patients affected by Parkinson's disease (PD) with respect to the general population and to evaluate…
  • « Previous Page
  • 1
  • …
  • 1391
  • 1392
  • 1393
  • 1394
  • 1395
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley